A carregar...

Phase I study of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer

This phase I was study conducted to establish the maximum tolerated dose, dose-limiting toxicity, and recommended dose of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer. Twenty-six patients were treated with cyclophosphamide (600 mg m(−2), intr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Vasey, P A, Roché, H, Bisset, D, Terret, C, Vernillet, L, Riva, A, Ramazeilles, C, Azli, N, Kaye, S B, Twelves, C J
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2002
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2376193/
https://ncbi.nlm.nih.gov/pubmed/12402144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600626
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!